// App-Quantinova.ai

: TREATMENT OF FAVORABLE RISK YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) USING A LOW-DENSE/ LOW-INTENSE CHEMOTHERAPY PROTOCOL

Researchers

Presenter

  • Maher Salamoon

Principal Investigators

  • mehdi balti

  • khaled ghanem

  • mazen kenj

Medical Centers

  • hematology,al bairouni university cancer center,damascus,Syrian Arab Republic

  • hematology,hopital militaire principal d'instruction,tunis,Tunisia

  • hematology,Basma charity,damascus,Syrian Arab Republic

  • cytogenetic,al assad university hospital,damascus,Syrian Arab Republic

Locations

  • Tunisia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • 6-mercaptopurine

  • Allmercap

  • Methotrexate

  • Prednisolone

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved